{"member_organisations": "Partners of the EEIG \nsee http://www.euvaccine.eu/about-us/governance/board", "identification_number": "488745629660-19", "fields_of_interest": "Research and innovation, Public Health", "head_office_address": "Vo\u00dfstrasse 2 Building 4040", "full_time_equivalent_fte": "0,5", "person_with_legal_responsibility": "Odile Leroy", "financial_year_start_date": "01/01/2016", "grants": "4894059", "country_code": "DE", "head_office_country": "Germany", "eu_initiatives": "EVI is following  policies and laws of: \nEU directive on Clinical trials \nEUDRACT \nEUDRALEX \nEuropean Medicine Agency \nJoint Research Center \nNational Regulatory agencies", "level_of_interest": "global", "organisation_name": "European Vaccine Initiative (EVI)", "belgium_office_post_code": "", "procurement": "0", "section": "III - Non-governmental organisations", "lon": 8.68951, "source": "na", "belgium_office_address": "", "belgium_office_phone": "", "number_of_ep_accredited_persons": "", "overall_budget_turnover_as_a_range": "", "subsection": "Non-governmental organisations, platforms and networks and similar", "no_geo_reference": true, "persons_accredited_for_access_to_european_parliament_premises": "", "estimate_of_costs_absolute_amount": "", "registration_date": "17/01/2018", "website_address": "http://www.euvaccine.eu", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Heidelberg", "membership": "", "head_office_post_code": "69115", "goals__remit": "The European Vaccine Initiative (EVI) is leading European efforts to develop effective, accessible, and affordable vaccines against diseases of poverty. EVI\u2019s vision is 'a world free of the intolerable burden of diseases of poverty within the coming decades. \nEVI is contributing to the global efforts to control these diseases in three main ways: \n1. Creating an environment to accelerate the development and clinical assessment of vaccine candidates for diseases of poverty \n2. Promoting affordability and accessibility of vaccines for diseases of poverty in low income populations \n3.Seeking to align all major stakeholders and acting as a focal point to ensure the successful development of vaccines for diseases of poverty for low income populations.", "industry_forums": "", "inter_groups": "", "number_of_persons_involved": "2", "relevant_communication": "Please refer to website \nhttp://www.euvaccine.eu/news-events", "financial_year_end_date": "01/12/2016", "lat": 49.40992, "estimate_of_costs_as_a_range": "10000-24999", "overall_budget_turnover_absolute_amount": "7257481", "legal_status": "European Economic Interesting Group", "person_in_charge_of_eu_relations": "Stefan Jungbluth", "customers": "", "belgium_office_post_box": "", "position": "Head of Business Development", "belgium_office_city": "", "head_office_phone": "(+49)6221566524"}